Types of Necrosis — Coagulative, Liquefactive, Caseous, Fat, Fibrinoid, Gangrenous

Common Mechanisms to All Types

• Loss of ATP production → failure of Na+/K+-ATPase → cellular swelling (oncotic necrosis)
• Loss of membrane integrity → leakage of hydrolytic enzymes and DAMPs (danger-associated molecular patterns)
• Denaturation of proteins → irreversible structural damage
• Calcium influx → activation of proteases, phospholipases, endonucleases

COAGULATIVE NECROSIS

• Mechanism: Ischemic hypoxia with preserved tissue architecture ("ghost cells")
• Histology: Loss of nuclei and cellular detail but maintenance of tissue outline
• Timeline: Acute phase (0-6 hours) shows viable appearance; by 6-12 hours, nuclei disappear; by 24 hours, coagulum forms
• Molecular basis: Denaturation of structural proteins (myosin, actin) and lysosomal enzymes remain compartmentalized (minimal enzymatic digestion)
• Predominant tissue: Heart, kidney, liver (all except CNS and bacteria-rich tissues)

LIQUEFACTIVE NECROSIS

• Mechanism: Complete tissue dissolution due to enzymatic digestion by host and bacterial proteases
• Histology: Liquefied center with abscess formation; rim of neutrophils and macrophages
• Enzymatic basis: Hydrolytic enzymes from neutrophils and macrophages digest tissue faster than tissue can wall off the lesion
• Bacterial involvement: Liquefactive necrosis in brain or lungs typically indicates bacterial infection (Staphylococcus, Streptococcus, gram-negatives)
• CNS special case: Even sterile ischemic infarcts in brain show liquefactive pattern due to high lipid content and minimal structural protein; lipases and phospholipases dissolve lipid-rich white matter

CASEOUS (CASEATING) NECROSIS

• Mechanism: Combination of coagulative and liquefactive patterns
• Distinctive feature: Acellular granular debris with NO preservation of tissue architecture (unlike coagulative) but WITHOUT liquid center (unlike liquefactive)
• Microscopy: Amorphous, eosinophilic debris surrounded by epithelioid histiocytes and Langhans giant cells
• Immunological basis: Type IV hypersensitivity reaction to Mycobacterium tuberculosis; mycobacterial antigens trigger CD4+ T cells and macrophage activation
• Molecular markers: Lack of mycobacterial clearance → chronic granulomatous inflammation with TNF-α and IFN-γ driving necrosis
• Distinguishing feature from coagulative: Tissue outline is obliterated; from liquefactive: no purulent fluid

FAT NECROSIS

• Mechanism: Pancreatic or peripancreatic lipase release → hydrolysis of triglycerides into free fatty acids
• Chemistry: Free fatty acids bind calcium → formation of calcium soaps (saponification)
• Histology: Amorphous eosinophilic material with chalk-like deposits (calcium); ghost outlines of fat cells; infiltration by macrophages and neutrophils
• Gross appearance: Yellow-white chalky areas with firm consistency
• Context: Usually associated with acute pancreatitis; can also occur with trauma to fatty tissues
• Distinction: Often considered a form of enzymatic necrosis rather than true ischemic necrosis

FIBRINOID NECROSIS

• Mechanism: Severe endothelial injury with vessel wall necrosis and leakage of fibrinogen into tissue
• Histology: Amorphous, bright pink (eosinophilic) homogeneous material on H&E; fibrin deposits without cellular structure
• Immunological basis: Immune complex deposition (Type II and III hypersensitivity) or severe hypertension causing endothelial denudation
• Associated conditions: Vasculitis (polyarteritis nodosa, microscopic polyangiitis), malignant hypertension, rheumatic fever, lupus
• Molecular: Antibody-complement mediated injury or direct endothelial cytotoxicity; loss of vessel wall integrity

GANGRENOUS NECROSIS

• Mechanism: NOT a distinct type but rather coagulative necrosis + secondary bacterial colonization + liquefaction at margins
• Dry gangrene: Ischemic coagulative necrosis; sharp demarcation between viable and dead tissue; minimal bacterial colonization
• Wet gangrene: Ischemia + superimposed bacterial infection; diffuse liquefactive changes at periphery; spreading inflammation
• Gas gangrene (clostridial): Caused by Clostridium perfringens; produces alpha toxin (phospholipase C) causing rapid muscle necrosis with gas formation
• Clinical progression: Dry → wet occurs with secondary infection or continued ischemia

COAGULATIVE NECROSIS

• Myocardial infarction (atherosclerotic coronary artery occlusion)
• Renal infarction (thromboembolism, dissection, vasculitis)
• Hepatic infarction (portal vein thrombosis, severe congestion)
• Splenic infarction (emboli, vasculitis)
• Acute mesenteric ischemia (atherosclerosis, embolism, thrombosis)
• Cerebral infarction (when coagulative pattern predominates in early stages before liquefaction)
• Risk factors: Atherosclerosis, thrombophilia, arrhythmias, vasculitis

LIQUEFACTIVE NECROSIS

• Brain infarction (bacterial or fungal infection; ischemic stroke → liquefaction after 48-72 hours)
• Abscess formation (Staphylococcus aureus, Streptococcus, E. coli, anaerobes)
• Lung abscess (aspiration pneumonia, necrotizing infections)
• Bacterial meningitis (pus formation in subarachnoid space)
• Risk factors: Immunosuppression, aspiration, poor hygiene, diabetes

CASEOUS NECROSIS

• Tuberculosis (Mycobacterium tuberculosis) — most common cause
• Mycobacterial infections (M. avium complex in HIV/AIDS)
• Fungal infections (Histoplasma, Blastomyces, Coccidioides — rare)
• Syphilis (gummas in tertiary disease — very rare)
• Risk factors: HIV/AIDS, malnutrition, immunosuppression, prior TB exposure

FAT NECROSIS

• Acute pancreatitis (most common — 85-90% of cases)
• Alcohol abuse
• Biliary stones
• Post-ERCP
• Hypertriglyceridemia
• Medications (azathioprine, corticosteroids, valproate)
• Abdominal trauma
• Blunt abdominal trauma (direct pancreatic injury)
• Breast trauma (fat necrosis in breast tissue)
• Risk factors: Gallstones, alcoholism, hypercalcemia, autoimmune pancreatitis

FIBRINOID NECROSIS

• Vasculitis (polyarteritis nodosa, microscopic polyangiitis, Granulomatosis with polyangiitis)
• Malignant hypertension (>180/120 mmHg with end-organ damage)
• Rheumatic fever (Aschoff bodies in myocardium)
• Systemic lupus erythematosus (wire-loop lesions in renal glomeruli)
• Type II hypersensitivity (anti-basement membrane disease, Goodpasture syndrome)
• Risk factors: Uncontrolled hypertension, autoimmune disease, ANCA-positive vasculitis

GANGRENOUS NECROSIS (DRY)

• Atherosclerotic peripheral arterial disease (lower extremities)
• Thromboembolism (arterial occlusion)
• Diabetes mellitus (with concurrent neuropathy)
• Raynaud phenomenon (severe vasospasm)
• Risk factors: Age, smoking, diabetes, hypertension

GANGRENOUS NECROSIS (WET)

• Secondary bacterial infection of ischemic tissue
• Clostridial gas gangrene (Clostridium perfringens, novyi, histolyticum)
• Penetrating trauma with soil contamination
• Crush injuries
• Post-surgical infections
• Risk factors: Contaminated wounds, delayed treatment, immunosuppression

COAGULATIVE NECROSIS (Myocardial Infarction Example)

• Cardinal symptoms: Chest pain (substernal, crushing, radiating to left arm/jaw), dyspnea, diaphoresis, nausea
• Timeline: Symptom onset at ischemia; necrotic changes visible by 4-12 hours histologically
• Physical exam: Hypotension, tachycardia, signs of heart failure (rales, S3 gallop), arrhythmias
• Lab findings: Elevated troponin I/T (released from damaged myocytes at 2-4 hours, peak 24-48 hours), elevated creatine kinase-MB, elevated LDH, elevated myoglobin
• Imaging: ECG shows ST-segment elevation or T-wave inversion; echocardiography shows wall motion abnormality; cardiac MRI shows delayed gadolinium enhancement
• Morphological correlate: Pale, firm tissue at 24-48 hours; hyperemic border at 3-7 days

LIQUEFACTIVE NECROSIS (Abscess Example)

• Cardinal symptoms: Localized pain, fever, chills, systemic malaise
• Local signs: Fluctuance, erythema, warmth, induration, possible pus drainage if superficial
• Systemic signs: Fever (>38.5°C), tachycardia, tachypnea
• Lab findings: Elevated WBC (left shift), elevated inflammatory markers (ESR, CRP), positive bacterial cultures from aspirate
• Imaging: Ultrasound shows hypoechoic/anechoic center with hyperechoic wall; CT/MRI shows fluid collection with rim enhancement
• Morphological correlate: Liquid pus in center; yellow-green color if purulent

CASEOUS NECROSIS (Tuberculosis Example)

• Systemic symptoms: Fever (afternoon/evening spikes), night sweats, chills, weight loss, fatigue
• Pulmonary symptoms (if TB): Chronic productive cough (>3 weeks), hemoptysis, chest pain on breathing
• Constitutional signs: Wasting, cachexia, hepatosplenomegaly (disseminated disease)
• Lab findings: Acid-fast positive (Ziehl-Neelsen or auramine-rhodamine stain) organisms on sputum; tuberculin skin test (TST) positive (>5 mm induration in high-risk); elevated inflammatory markers
• Imaging: CXR shows upper lobe infiltrates, cavitary lesions with air-fluid levels
• Histological finding: Granuloma with central caseous necrosis surrounded by epithelioid histiocytes and Langhans giant cells

FAT NECROSIS (Acute Pancreatitis Example)

• Cardinal symptom: Severe epigastric pain radiating to back, worse with food/alcohol
• Physical exam: Epigastric tenderness, guarding, possible Cullen sign (periumbilical bruising) or Grey Turner sign (flank bruising) indicating hemorrhagic pancreatitis
• Laboratory:
• Elevated amylase (>3× upper limit normal) — sensitive but NOT specific
• Elevated lipase (>3× upper limit normal) — more specific for pancreatitis
• Elevated transaminases, hyperbilirubinemia (if biliary obstruction)
• Hypocalcemia (from calcium sequestration in saponified fat)
• Hyperglycemia (pancreatic damage)
• Imaging: CT abdomen shows pancreatic enlargement, peripancreatic fat stranding, fluid collections
• Morphological correlate: Yellow-white chalky areas with firm texture

FIBRINOID NECROSIS (Malignant Hypertension Example)

• Acute symptoms: Severe headache, visual disturbances, chest/back pain, dyspnea
• Physical exam: BP >180/120 mmHg, retinopathy with flame hemorrhages and cotton-wool spots, papilledema, altered mental status
• End-organ damage signs:
• Renal: Oliguria, hematuria, proteinuria
• Cardiac: Pulmonary edema, chest pain
• Neurological: Seizures, focal deficits, encephalopathy
• Lab findings: Elevated creatinine, microscopic hematuria with RBC casts, elevated LDH, decreased haptoglobin (if microangiopathic hemolytic anemia present)
• Imaging: Renal biopsy shows "onion-skinning" of arterioles
• Morphological correlate: Bright pink, homogeneous appearance on H&E

GANGRENOUS NECROSIS — DRY GANGRENE (Peripheral Arterial Disease)

• Cardinal symptom: Claudication (leg pain with walking), rest pain
• Progression: Cool extremity → cyanosis → black, mummified tissue (dry gangrene)
• Physical exam: Pale or cyanotic limb, absent pulses distally, sharp demarcation between viable and necrotic tissue, no edema
• Sensory/motor: Paresthesias, weakness (neuropathy component in diabetes)
• Lab: Elevated inflammatory markers if infection supervenes
• Imaging: Angiography shows critical stenosis/occlusion; duplex ultrasound shows no flow

GANGRENOUS NECROSIS — WET GANGRENE (Infected Tissue)

• Cardinal symptom: Severe pain at margin of necrosis
• Systemic toxicity: High fever, hypotension, altered mental status (sepsis)
• Local signs: Edema extending beyond demarcation line, purulent drainage, cellulitis, putrid odor (indicates bacterial overgrowth)
• Physical exam: Blurred margin between viable/necrotic tissue (unlike dry); possible crepitus if gas-forming organisms
• Lab: Elevated WBC with left shift, positive blood cultures, elevated lactate (tissue hypoperfusion), thrombocytopenia
• Imaging: Subcutaneous gas on X-ray or CT (in clostridial infection)

GAS GANGRENE (Clostridial) — Special Variant

• Acute onset: 6-48 hours post-trauma or surgery
• Pain: Excruciating, out of proportion to exam findings
• Systemic signs: Toxic appearance, shock, renal failure, hemolytic anemia
• Local signs: Muscle swelling, brawny edema, hemorrhagic bullae, skin crepitus (pathognomonic), bronze or purple discoloration
• Lab: Elevated creatine kinase (myonecrosis), hemolysis (elevated indirect bilirubin, low h

• Coagulative (infarct): ECG within 10 minutes of chest pain, then serial high-sensitivity troponin using a 0/1- or 0/2-hour algorithm (Fourth Universal Definition of MI; ACC/AHA acute coronary syndrome guidance). A rise-and/or-fall pattern with ischemic symptoms establishes infarction. A new LBBB is not a stand-alone STEMI criterion — apply Sgarbossa (or modified Sgarbossa) criteria. Renal/splenic infarcts appear as wedge-shaped, non-enhancing defects on contrast CT.
• Liquefactive: contrast CT/MRI shows a ring-enhancing collection; brain abscess restricts on diffusion-weighted imaging, which separates it from necrotic tumor. Confirmation is aspiration with Gram stain and culture; pus with a neutrophil-rich rim is the histologic correlate.
• Caseous: sputum AFB smear plus a nucleic acid amplification test (Xpert MTB/RIF) on initial specimens per CDC/ATS/IDSA; mycobacterial culture remains the gold standard and provides susceptibilities. Biopsy shows caseating granuloma with Langhans giant cells. IGRA/TST diagnose infection, not active disease.
• Fat: Revised Atlanta classification — 2 of 3 (characteristic epigastric pain, lipase or amylase ≥3× upper limit of normal, or cross-sectional imaging findings). Contrast CT is deferred ~72 hours to detect necrosis. Severity is graded with BISAP or Ranson criteria. Breast fat necrosis shows oil cysts with eggshell calcification on mammography.
• Fibrinoid: severe hypertension with end-organ injury, RBC casts on urinalysis, schistocytes with elevated LDH and low haptoglobin; ANCA/ANA/complement studies for vasculitis. Biopsy is definitive, showing bright eosinophilic vessel-wall material.
• Gangrenous: ankle-brachial index and toe pressures with SVS WIfI staging for limb ischemia; plain film/CT for soft-tissue gas. LRINEC is an adjunct only — surgical exploration is the diagnostic gold standard for necrotizing infection.

Cause-directed first-line therapy

• Coagulative/ischemic necrosis (STEMI): reperfusion is the therapy — primary PCI within 90 minutes of first medical contact, or fibrinolysis if PCI is unavailable within 120 minutes (ACC/AHA). Adjuncts: antiplatelet therapy (aspirin plus a P2Y12 inhibitor), anticoagulation, high-intensity statin (atorvastatin), and a beta blocker once hemodynamically stable.
• Liquefactive necrosis (abscess): source control first — drainage or aspiration. Empiric antibiotics per IDSA; anti-MRSA coverage with vancomycin dosed to a 24-hour AUC targeting AUC/MIC 400–600 (2020 IDSA/ASHP consensus), not a 15–20 mcg/mL trough.
• Caseous necrosis (TB): multidrug therapy only — RIPE (rifampin, isoniazid, pyrazinamide, ethambutol) with an intensive then continuation phase, plus pyridoxine, under directly observed therapy (ATS/CDC/IDSA). Monotherapy is contraindicated: it selects resistance.
• Fat necrosis (pancreatitis): goal-directed moderate fluid resuscitation with lactated Ringer's, analgesia, and early enteral nutrition (ACG). Prophylactic antibiotics for sterile necrosis are not recommended.
• Fibrinoid necrosis (hypertensive emergency): IV titratable agents — clevidipine, nicardipine, or labetalol — lowering MAP by no more than about 25% in the first hour (ACC/AHA hypertension guideline), with exceptions for aortic dissection. Immune-mediated fibrinoid necrosis requires corticosteroids plus a cytotoxic/biologic agent (cyclophosphamide or rituximab) per ACR vasculitis guidance.
• Gangrenous necrosis: dry gangrene — revascularization (endovascular or bypass) per SVS, then delayed amputation at the demarcation line. Wet/gas gangrene — emergent radical debridement or amputation, plus penicillin combined with clindamycin for toxin suppression (IDSA); broad empiric coverage until cultures return.

Disease-related — mechanism and the sign that reveals it

• Myocardial free wall rupture: macrophage-mediated collagenolysis peaks in the necrotic zone days after infarction → sudden hypotension, JVD, muffled heart sounds, pulseless electrical activity. Emergency — tamponade requiring pericardiocentesis and surgery.
• Papillary muscle rupture / VSD: new holosystolic murmur with acute pulmonary edema or an oxygen step-up on right-heart catheterization. Emergency.
• Ventricular aneurysm and mural thrombus: fibrotic thinning with stasis → persistent ST elevation weeks after MI, systemic embolism.
• Malignant arrhythmia: necrotic tissue creates reentry → ventricular fibrillation / pulseless VT, the shockable pair requiring immediate defibrillation. Emergency.
• Cerebral liquefaction: cavitation with cytotoxic edema → declining consciousness, herniation. Emergency requiring osmotic therapy or decompressive craniectomy.
• Cavitary TB: erosion into a bronchial vessel (Rasmussen aneurysm) → massive hemoptysis; healed cavities may harbor aspergilloma (fungus ball, mobile on decubitus imaging).
• Pancreatic fat necrosis: calcium soap formation → hypocalcemia with Chvostek/Trousseau signs; walled-off necrosis that becomes infected (new fever, gas within the collection) is managed by a delayed endoscopic step-up approach; splenic vein thrombosis → isolated gastric varices.
• Fibrinoid necrosis: microangiopathic hemolysis with schistocytes, oliguric AKI, hypertensive encephalopathy, seizures. Emergency.
• Gangrene: bacteremia and septic shock, rhabdomyolysis with hyperkalemia and pigment nephropathy; clostridial toxin causes intravascular hemolysis.

Treatment-related

• Reperfusion injury: calcium overload and free radicals → accelerated idioventricular rhythm after PCI (usually benign) and contraction-band necrosis.
• Fibrinolytic therapy: intracranial hemorrhage — a new headache or focal deficit demands emergent non-contrast CT. Emergency.
• Vancomycin: AKI risk rises with excessive AUC exposure, especially with piperacillin-tazobactam.
• Antitubercular drugs: isoniazid hepatotoxicity and neuropathy (prevent with pyridoxine), ethambutol optic neuritis (red-green color loss), pyrazinamide hyperuricemia, rifampin CYP induction with orange body fluids.
• Overly rapid BP reduction: loss of autoregulation → watershed infarction.

• Coagulative necrosis preserves the tissue outline — ghost cells with anucleate eosinophilic myocytes and a wedge-shaped pale infarct. Ischemia in essentially every solid organ produces this pattern.
• The brain is the exception: ischemic stroke yields liquefactive necrosis because of high lipid, low structural protein content and microglial hydrolases — the end product is a fluid-filled cyst with gliosis, not a scar. This exception is the single most tested distractor in the topic.
• Caseous necrosis = granuloma + loss of architecture without pus. Buzzword is cheese-like, friable; look for Langhans giant cells and a positive acid-fast stain. Best next step in a suspected pulmonary case is sputum AFB smear plus NAAT, not empiric monotherapy.
• Saponification is the fat necrosis signature: lipase liberates free fatty acids that chelate calcium → chalky white deposits and hypocalcemia. A falling serum calcium in pancreatitis signals severity, not a laboratory error.
• Fibrinoid necrosis means vessel wall injury — bright pink amorphous material in the wall. The association examiners test is malignant hypertension and immune-complex vasculitis (polyarteritis nodosa, lupus); Aschoff bodies in rheumatic fever are the classic eponym.
• Gangrene is not a separate histologic entity — it is coagulative necrosis (dry) that becomes liquefactive when bacteria superinfect (wet). Do not answer "gangrenous necrosis" when the stem asks for the microscopic pattern.
• Pain out of proportion to exam plus crepitus after a contaminated wound = clostridial myonecrosis from alpha toxin (lecithinase/phospholipase C). The single best next step is emergent surgical exploration and debridement, not CT imaging or antibiotics alone.
• Necrosis versus apoptosis: necrosis is ATP-depleted, membrane-disrupted, and inflammatory; apoptosis is ATP-dependent, membrane-intact, caspase-driven, and non-inflammatory. Nuclear sequence in necrosis is pyknosis → karyorrhexis → karyolysis.
• Breast fat necrosis after trauma mimics carcinoma clinically; mammography shows an oil cyst with eggshell calcification, and tissue diagnosis resolves the question.